Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Liftstream Releases Board Director and CEO Compensation and Governance 2015 Report – San Diego Biotechnology Cluster

Executive committee leadership and oversight by experienced and skilled boards will improve performance and governance of the biotechnology companies driving innovation. Understanding the landscape of corporate governance in biotech clusters will help companies evaluate their own boards’ strength.

Read the full article…

Posted in Corporate Governance | Tagged , , , , | Leave a comment

Recruiters Must Exercise Their Options on Executive Pay

Fair and equitable compensation is a challenge which grips leaders at all levels of the corporate ladder. It is CEOs and Boards who often receive the brunt of the hostile objections to what are viewed as excessive rewards. While undershooting on compensation also provokes equally audible protestations among those who wish for the company to continue to attract market leading talent and retain it effectively. For many, the correlation between financial rewards and quality talent is incontestable. For others, the connection is more opaque and the financial gains seen as disproportionate.

Read the full article…

Posted in Corporate Governance, Recruitment Market | Tagged , , , , , , , , , , , , , | Leave a comment

Biotechnology Cluster Spotlight – San Diego Biotechnology Cluster

The San Diego biotechnology cluster is among the top biotech clusters in the US. Life sciences activity accounts for more than $31.8 billion of economic impact in San Diego. According to California Life Sciences Industry 2016 Report (here), San Diego biotech cluster employed 38,061 people in 2014.

Read the full article…

Posted in General | Tagged , , , , | Leave a comment

Zavante Therapeutics Closes Series A Financing And Brings Directors To Board

Zavante Therapeutics, a late clinical-stage biopharmaceutical company based in San Diego, California, has closed a $45 million Series A financing, consisting of $35 million from new investors and $10 million from the conversion of outstanding convertible notes.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , | Leave a comment

aTyr Pharma Names Chief Medical Officer

aTyr Pharma, a San Diego-based biotherapeutics company addressing  rare diseases, has appointed Sanjay Shukla as Chief Medical Officer. Shukla will lead aTyr’s clinical efforts to advance its Physiocrine biology therapeutic intervention points and develop medicines that promote tissue homeostasis for patients with rare diseases.

Read the full article…

Posted in Executive Appointments | Tagged , , | Leave a comment

Adaptive Biotechnologies To Build Therapeutics Division

Adaptive Biotechnologies, a sequencing and bioinformatics company based in Seattle, Washington, has appointed Diego Miralles as president of Adaptive Therapeutics. Miralles will build the Therapeutics Division of Adaptive, and head the company’s efforts to leverage its platform for identifying T- and B-cell receptors for use in therapies. He will provide both scientific and commercial guidance to the existing and future programs and partnerships that Adaptive is implementing

Read the full article…

Posted in Executive Appointments | Tagged , , | Leave a comment

Mirati Therapeutics Promotes Chief Financial Officer

Mirati Therapeutics, a targeted oncology company based in San Diego, California, has promoted Vice President of Finance Jamie A. Donadio to Senior Vice President and Chief Financial Officer. In his new role, Donadio will be responsible for all corporate finance and accounting activities for the company.

Read the full article…

Posted in Executive Appointments | Tagged , , | Leave a comment

U.S. and South Korean Firms Form Joint Venture

Sorrento Therapeutics, clinical-stage biopharmaceutical company in San Diego, and Yuhan Corporation, an established health care company based in Seoul, have entered into an agreement to form a joint venture, ImmuneOncia Therapeutics. The joint venture will develop and commercialise a number of immune checkpoint antibodies against undisclosed targets for both hematological malignancies and solid tumors.

Read the full article…

Posted in Pharmaceutical business | Tagged , , | Leave a comment

Editas Medicine Appoints John D. Mendlein to Board of Directors

Editas Medicine, a genome editing company based in Cambridge, Mass, has appointed John D. Mendlein to its board of directors. Mendlein has served as CEO of aTyr Pharma since 2011, as well as executive chairman for the company from July 2010 to January 2016.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , | Leave a comment

Amplyx Pharmaceuticals Announces Trio of Appointments

Amplyx Pharmaceuticals, a San Diego-based company developing antifungal agents for the treatment of life-threatening fungal infections, has appointed Michael Hodges as chief medical officer, Karen Shaw as vice president of biology, and Elizabeth Gordon as vice president of regulatory affairs. The firm recently raised an USD8.7 million investment from 3×5 Partners, increasing its series B financing to USD49.2 million.

Read the full article…

Posted in Executive Appointments | Tagged , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap